Derivation of a clonal HEK293 suspension cell line for high yield AAV production

被引：0
|
作者：
Mcilhatton, M. [1 ]
Hurley, B. [1 ]
Bergman, S. [1 ]
Roodhouse, H. [1 ]
Carper, B. [1 ]
Janson, M. [1 ]
Ketz, J. [1 ]
Acharya, S. [1 ]
机构：
[1] Andelyn Biosci, 5185 Blazer Pkwy, Dublin, OH USA
来源：
HUMAN GENE THERAPY | 2022年 / 33卷 / 23-24期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P301
引用
收藏
页码：A106 / A106
页数：1
相关论文
共 50 条
  • [1] Strategy for Derivation and Optimization of a Clonal HEK293 Suspension Cell Line for High Yield AAV Production
    Mcilhatton, Michael A.
    Ketz, John
    Bergman, Sarah
    Hurley, Brittany
    Carper, Byron
    Moreo, Andrew
    Acharya, Samir
    [J]. BIOPHARM INTERNATIONAL, 2024, 37 (05)
  • [2] Chemically Defined and High-Yield AAV Vector Production Medium for Suspension HEK293 Based Cell Lines
    Nishie, Toshikazu
    Takeichi, Kaho
    Uemura, Kumiko
    Sakamoto, Shuhei
    Miura, Toshiyuki
    Ishihara, Daishi
    Chono, Hideto
    Okamoto, Sachiko
    Enoki, Tatsuji
    Mineno, Junichi
    [J]. MOLECULAR THERAPY, 2023, 31 (04) : 446 - 446
  • [3] HEK293 Suspension Single Clonal Cell Line Readiness for High Productivity of Viral Vector Manufacturing
    Dong, Yiyu
    Tran, Annie
    Lee, Ji-Hyun
    Guillemette, Garrett
    Yang, Jingpu
    Burke, Devin
    Hsu, Felix
    Fitch, R. J.
    Chang, David
    Jiang, Man-Shiow
    [J]. MOLECULAR THERAPY, 2022, 30 (04) : 192 - 192
  • [4] Clarification Studies on HEK293 Cell Lysate for AAV Production
    Gursky, Blake
    Belcher, Donald
    Davis, Corben
    Bodey, Elijah
    Yung, Bryant
    Davis, Adam
    Agbogbo, Frank
    Dismuke, David
    [J]. MOLECULAR THERAPY, 2022, 30 (04) : 190 - 190
  • [5] Upscaling AAV production for research purposes: development of HEK293 suspension cell-based AAV production protocol
    Pietersz, K. L.
    Klunder, M. H. M.
    Hobo, B.
    van den Herik, J.
    Nijhuis, P. J. H.
    de Winter, F.
    Verhaagen, J.
    [J]. HUMAN GENE THERAPY, 2022, 33 (23-24) : A112 - A112
  • [6] Scalable and high-titre lentiviral vector production from cGMP-compliant clonal suspension HEK293 cell line
    Krakowiak, J.
    Tomas, H.
    Keller, L. E.
    Efstathiou, A.
    Parker-Manuel, R.
    Macchiarulo, E.
    Zhang, L.
    Liu, Q.
    Cawood, R.
    Payne, T.
    [J]. HUMAN GENE THERAPY, 2019, 30 (11) : A32 - A33
  • [7] Optimizing Suspension HEK293 Transfection Processes for AAV Productivity
    Achwei, Helen
    Downing, Shawna
    Jenkins, Jenna
    Lee, Sangmook
    Fang, Kun
    Rogers, Benjamin
    Gee, Gretchen
    McNally, David
    Ganesa, Shekar
    Loiler, Scott
    [J]. MOLECULAR THERAPY, 2020, 28 (04) : 377 - 377
  • [8] HEK293 Transcriptome evaluation for efficient AAV production
    Kahlig, C. I.
    Pistek, M.
    Kraus, B.
    Bort, J. A. Hernandez
    [J]. HUMAN GENE THERAPY, 2022, 33 (23-24) : A115 - A116
  • [9] Production of High-Yield Adeno Associated Vector Batches Using HEK293 Suspension Cells
    Pietersz, Kimberly L.
    Nijhuis, Paul J. H.
    Klunder, Matthijs H. M.
    van den Herik, Joelle
    Hobo, Barbara
    de Winter, Fred
    Verhaagen, Joost
    [J]. JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2024, (206):
  • [10] Large Scale Suspension Production of AAV Capsid Variant Libraries from Stable Recombinant HEK293 Cell Banks
    Todorov, Gueorgui
    Tai, Alex
    Long, Steven
    Lindquist, Alissa
    Ngoc Nguyen
    Gasmi, Mehdi
    Cepeda, Diana
    [J]. MOLECULAR THERAPY, 2020, 28 (04) : 195 - 195
12345